|
|
|
|
|
06.02.26 - 22:03
|
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire EN)
|
|
|
NAARDEN, The Netherlands and MIAMI, Feb. 06, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam's Board of Directors approved the grant of inducement share options covering an aggregate of 217,000 of NewAmsterdam's ordinary shares to four (4) non-executive new hires. The share options were granted as an inducement material to the employees' acceptance of employment with NewAmsterdam pursuant to the NewAmsterdam Pharma Company N.V. 2024 Inducement Plan (the “2024 Inducement Plan”) and in accordance with Nasdaq Listing Rule 5635(c)(4)....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
06.02.26 - 18:42
|
Börsenradio Schlussbericht, Fr., 06.02.2026: DAX kontert - Big Tech verliert in einer Woche 1 Billion USD. Amazon -8 % (BRN)
|
|
|
DAX mit Gegenreaktion nach drei Verlusttagen: +0,94 % auf 24.721,46 Punkte. An der Wall Street stoppen Aktien eine dreitägige Talfahrt, weil nach schwächeren Jobdaten die Hoffnung auf Zinssenkungen zurückkommt. Gleichzeitig werden Big Tech Aktien "zerlegt": In einer Woche verschwanden rund 1 Billion USD Börsenwert, Amazon rutschte 8 % ab. Bitcoin zeigte wieder seine typischen Ausschläge: bis 60.000 USD runter, dann +9 % Erholung. Stellantis meldet 22 Mrd. Euro Abschreibungen, erwartet für die zweite Jahreshälfte einen vorläufigen Verlust von 19 bis 21 Mrd. Euro und zahlt keine Dividende. Renk springt nach Hochstufung bis zu 6,1 %, Rheinmetall erholt sich knapp 2 %. Bayer profitiert von Asundexian News, die Aktie +2,7 % in der Nachbörse. Coty bricht vorbörslich 14 % auf 2,71 USD ein, Verlust 126,9 Mio. USD....
|
|
|
|
|
|
|
|
|
06.02.26 - 18:09
|
Siemens Healthineers Overweight (DPA-AFX)
|
|
|
LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für Siemens Healthineers nach einem Gespräch mit Managern des Medizintechnikkonzerns auf "Overweight" mit einem Kursziel von 59 Euro belassen. Hassan Al-Wakeel hob in ......
|
|
|
06.02.26 - 18:06
|
Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery (GlobeNewswire EN)
|
|
|
Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical Research center in San Diego, California, designed to provide world-class scientific infrastructure and drug-discovery capabilities to advance the company's pipeline for patients. Once operational in 2029, the approximately 466,000-square-foot facility is expected to house about 1,000 Novartis employees and integrate seamlessly with Novartis global research sites including Cambridge, Massachusetts, and Basel, Switzerland, enabling integrated discovery efforts across regions.“This new research center will strengthen our scientific leadership and accelerate the discovery of transformative medicines for patients worldwide, while deepening our connectivity with biotech, academic and technology partners across the region,” said Fiona Marshall, President of Biomedical Research at Novartis. “Designed to power future drug discovery, with a focus on genetics and human biology in key therapeutic areas such as...
|
|
|
|
|
06.02.26 - 18:03
|
Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital (Business Wire)
|
|
|
Article L233-8-II of the Commercial Code
Article 223-16 of the General Regulations of the AMFPARIS--(BUSINESS WIRE)--Regulatory News:
Mauna Kea Technologies (Paris:ALMKT):
Listing: Euronext Growth Paris
ISIN code: FR0010609263, Ticker: ALMKT
Website: www.maunakeatech.com
Date
Number of shares comprising
the capital in circulation
Total number of voting rights
Gross Total (1)
Net Total (2)
January 31, 2026
192,202,823
193,286,360
193,286,360
(1) The gross number of voting rights (or "theoretical" voting rights) serves as the basis for calculating the thresholds. In accordance with Article 223-11 of the General Regulations of the AMF, this number is calculated on the basis of all shares carrying voting rights, including shares without voting rights.
(2) The net number of voting rights (or voting rights "exercisable in General Meeting") is calculated without considering the shares with suspended voting rights. It is published for proper public information in accordance with the AMF recomm...
|
|
|
|